Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
- 10 June 2004
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 43 (12) , 2326-2328
- https://doi.org/10.1016/j.jacc.2004.03.023
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Soluble CD40 ligand induces β 3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signalingProceedings of the National Academy of Sciences, 2003
- Membrane-associated CD40L and sCD40L in atherothrombotic diseaseThrombosis and Haemostasis, 2003
- Platelets in atherothrombosisNature Medicine, 2002
- CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanismNature Medicine, 2002
- Inflammatory role of platelets in acute coronary syndromesHeart, 2001
- Soluble CD40L and Cardiovascular Risk in WomenCirculation, 2001
- Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotypeProceedings of the National Academy of Sciences, 2000
- Requirement for CD154 in the progression of atherosclerosisNature Medicine, 1999
- Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable AnginaCirculation, 1999
- CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cellsNature, 1998